Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria. - Gansane A; Lingani M; Yeka A; Nahum A; Bouyou-Akotet M; Mombo-Ngoma G; Kaguthi G; Barceló C; Laurijssens B; Cantalloube C; Macintyre F; Djeriou E; et al. (Malaria journal, 2023)